trial · primary record
AH-008 for Injection, 150 mg
Chemotherapy-induced Peripheral Neuropathy (CIPN)
| Phase | Phase 1 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 32 |
| Primary completion | 2026-09-25 |
| Primary endpoint | Incidence of Treatment-Emergent Adverse Events (TEAEs) |
| Registry ID | NCT07697560 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:32:50.299Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07697560
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.